Clinical Trials Browser

Phase 2/3 × Liver Metastases × 90 days × Clear all

NCT04143516 2026-03-19

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Phase 2/3 Recruiting

Liver Metastases